Publications | Lund University Publications

1 – 10 of 16

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Foley%2C+J.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Foley%2C+J.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2014
Mark Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU ; Schweizer, A ; Foley, J E and Ahrén, Bo ^LU (2014) In Diabetes, Obesity and Metabolism 16(9). p.812-818
- Contribution to journal › Article
2013
Mark Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
Omar, Bilal ^LU ; Vikman, Jenny ^LU ; Sörhede Winzell, Maria ^LU ; Voss, Ulrikke ^LU ; Ekblad, Eva ^LU ; Foley, J E and Ahrén, Bo ^LU (2013) In Diabetologia 56(8). p.1752-1760
- Contribution to journal › Article
2011
Mark Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
Ahrén, Bo ^LU ; Foley, J E and Bosi, E (2011) In Diabetes, Obesity and Metabolism 13(3). p.193-203
- Contribution to journal › Article
Mark Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
Ahrén, Bo ^LU ; Schweizer, A. ; Dejager, S. ; Villhauer, E. B. ; Dunning, B. E. and Foley, J. E. (2011) In Diabetes, Obesity and Metabolism 13(9). p.775-783
- Contribution to journal › Scientific review
2010
Mark Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
Matthews, D. R. ; Dejager, S. ; Ahrén, Bo ^LU ; Fonseca, V. ; Ferrannini, E. ; Couturier, A. ; Foley, J. E. and Zinman, B. (2010) In Diabetes, Obesity and Metabolism 12(9). p.780-789
- Contribution to journal › Article
2009
Mark Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia
Gautier, J. F. ; Dejager, S. ; Foley, J. ; Halimi, S. and Ahrén, Bo ^LU (2009) In Diabetes & Metabolism 35. p.8-8
- Contribution to journal › Published meeting abstract
Mark Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
Ahrén, Bo ^LU ; Foley, J. ; Ferrannini, E. ; Matthews, D. ; Zinman, B. ; Dejager, S. and Fonseca, V. (2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.798-798
- Contribution to journal › Published meeting abstract
2008
Mark The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
Ahrén, Bo ^LU and Foley, J E (2008) In International journal of clinical practice. Supplement 62. p.8-14
- Contribution to journal › Article
Mark Vildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
Ahrén, Bo ^LU ; Schweizer, A. ; Dejager, S. ; Dunning, B. E. ; Persson, Margaretha ^LU and Foley, J. E. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.36-37
- Contribution to journal › Published meeting abstract
Mark Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
Scherbaum, W. A. ; Schweizer, A. ; Mari, A. ; Nilsson, Peter ^LU ; Lalanne, G. ; Jauffret, S. and Foley, J. E. (2008) In Diabetes, Obesity and Metabolism 10(8). p.675-682
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove author: Foley, J.